A detailed history of Central Pacific Bank Trust Division transactions in Eli Lilly & CO stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 10,564 shares of LLY stock, worth $8.41 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
10,564
Previous 11,340 6.84%
Holding current value
$8.41 Million
Previous $10.3 Billion 8.84%
% of portfolio
1.18%
Previous 1.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$772.14 - $960.02 $599,180 - $744,975
-776 Reduced 6.84%
10,564 $9.36 Billion
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $542,927 - $680,870
-749 Reduced 6.2%
11,340 $10.3 Billion
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $7.16 Million - $9.58 Million
12,089 New
12,089 $9.19 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.